US Patent Family Members and Approved Drugs for Denmark Patent: 0921812
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Denmark Patent: DK0921812
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,866,538 | 2016-06-20 | insulin aspart protamine and insulin aspart | Novo Nordisk Inc. | NOVOLOG MIX 70/30 |
| 5,866,538 | 2016-06-20 | menotropins | Ferring Pharmaceuticals Inc. | MENOPUR |
| 5,866,538 | 2016-06-20 | insulin degludec and insulin aspart | Novo Nordisk Inc. | RYZODEG 70/30 |
| 5,866,538 | 2016-06-20 | insulin aspart | Novo Nordisk Inc. | NOVOLOG |
| 5,866,538 | 2016-06-20 | insulin detemir | Novo Nordisk Inc. | LEVEMIR |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
